Atlas Trials

Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)

Clinical trial NCT05854784 · COMPLETED

Trial details

NCT number
NCT05854784
Sponsor
Clinuvel Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Variegate Porphyria
Start date
2023-03-28
Primary completion
2023-12-28
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.